Elsevier Business Intelligence announces the publication
of a new Special Report:
Medical Device Landscape:
How regulatory changes and cost control measures
are reshaping the industry
Originally published in Medtech Insight: Medical Technology Market
Intelligence®
While the
insurance industry and Big Pharma make headlines during the health care reform
debate, medical device manufacturers shouldn't relax their guard for even a
moment: From the rising clout of group purchasing organizations (GPOs) to
payment bundling and physicians' growing allegiance with hospitals in product
price negotiations, the device market is facing some of the most serious
challenges to its profits in years. How aggressive will GPOs get with device
companies? How has the tough economy impacted medical device funding? And what
can manufacturers do to help insure their success in this rapidly shifting
environment? This Special Report
answers all these questions and more with in-depth analysis of the impact of new device
regulations combined with new moves among payors to lower costs.
This detailed
24-page report is a must-read for every medical device reimbursement,
marketing, sales, business development and investment executive in medical
technology today, whether you're a device start up seeking funding, an
orthopedics executive struggling with the new device industry-physician
transparency laws, or even a sales rep wondering why your clients have stopped
returning your calls.
Prepared by Medtech Insight’s expert analysts,
the report spotlights how a vast range of cost-cutting, ethics and health care
reform measures are impacting the medical device industry, and forecasts
potential longterm effects of the upheaval.
This
Special Report examines ...
- How the bond between group purchasing
organizations and hospitals is growing stronger every day, and how the
burden of cost-cutting is now shifting from health care providers to
medical device manufacturers themselves
- CMS' three-year pilot program that will
experiment with single, bundled-payment systems for selected hospitals
serving orthopedic and cardiac patients
- The plethora of new rules and regulations
governing medical device companies and their relationships with
physicians, and how to stay on the right side of the law
- Why physicians are suddenly less likely to
purchase high-priced medical devices based on their own preferences, as in
the past, and are instead working with hospital management to develop
low-cost purchasing plans
- The perilous state of medical device funding,
from health care reform's dampening effect on investor enthusiasm to the
economy-based decline of once-reliable device VCs...and much more.
Click here
to ORDER NOW
It's all about the margins
What's driving hospitals
into the arms of aggressive GPOs? According to one GPO CEO, it's a rising tide
of bitterness at some hospitals toward manufacturers operating on high
margins, but still trying to pass along increasing costs to facilities
struggling financially. Nevertheless, this provides an unexpected
opportunity for device manufacturers who are willing to work with providers in
cutting costs to actually increase their market share.
The
threat to medical device innovation
Some changes coming down the
pike as part of health care reform could benefit hospitals, physicians and
patients, but what effect will they have on medical device manufacturers? The
device industry worries that letting hospitals make gang decisions through
payment bundling will cut them out of the decision-making process altogether,
creating an arid landscape for new technology and innovation.
Is it an
educational seminar or a golf outing?
What's a device manufacturer and its sales force to do? Now
that the health care regulatory watchdogs have spoken, pretty much any
traditional gifts, remunerations or consulting contracts with physicians are
off-limits. This report outlines the penalties already paid by prominent device
companies and explains that the scrutiny is getting even harsher. The solution
for confused executives? The "common-sense" or "straight
face" tests that you should use to decide what's ethical and what will get
you into hot water.
From product selection process to medical
device startup investment trends, these are just some of the issues and
actionable insight included in this must-read report. And it could only be
delivered by Medtech Insight, the premier resource for medical
technology intelligence, relied on by executives at a majority
of the top 50 medtech companies in the world.
ORDER NOW